IBRX - Immunitybio - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

IBRX is currently covered by 6 analysts with an average price target of $12.92. This is a potential upside of $6.94 (116.05%) from yesterday's end of day stock price of $5.98.

Immunitybio's activity chart (see below) currently has 58 price targets and 90 ratings on display. The stock rating distribution of IBRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 69.9% of the time, taking 328.39 days on average.

Highest price target for IBRX is $23, Lowest price target is $7, average price target is $12.92.

Most recent stock forecast was given by KELLY SHI from JEFFERIES on 15-Oct-2026. First documented stock forecast 24-Aug-2015.

Best performing analysts who are covering IBRX - Immunitybio:

Joshua Schimmer Biren Amin Kelly Shi Andrew Fein Andres Maldonado Justin Zelin

Currently out of the existing stock ratings of IBRX, 29 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Aug-2022

$14

$7.98 (132.56%)

$9

1 months 2 days ago
(15-Oct-2026)

2/3 (66.67%)

$4 (40.00%)

354

Buy Since 13-Mar-2025

$15

$8.98 (149.17%)

$15

5 months 15 days ago
(02-Jun-2026)

9/14 (64.29%)

$7.77 (107.47%)

198

Buy Since 12-Mar-2026

$12

$5.98 (99.34%)

$13

5 months 27 days ago
(21-May-2026)

0/3 (0%)

$4.26 (55.04%)

Buy Since 23-Oct-2024

$23

$16.98 (282.06%)

$23

6 months 12 days ago
(05-May-2026)

0/18 (0%)

$15.42 (203.43%)

Buy Since 20-Jan-2026

$12

$5.98 (99.34%)

$7

8 months 13 days ago
(04-Mar-2026)

2/3 (66.67%)

$3 (33.33%)

122

Show more analysts

Please expand the browser size to see the chart

What is IBRX (Immunitybio) average time for price targets to be met?

On average it took 328 days for the stock forecasts to be reached, with an average price target met ratio of 69.9%.

Which analyst most recently updated their price target on IBRX (Immunitybio)?

Kelly Shi

Which analyst has the most public recommendations on IBRX (Immunitybio)?

Kelly Shi works at JEFFERIES and has 11 price targets and 6 ratings on IBRX

Which analyst is the currently most bullish on IBRX (Immunitybio)?

Joshua Schimmer with the highest potential upside of $16.98

Which analyst is the currently most reserved on IBRX (Immunitybio)?

Joel Beatty with the lowest potential downside of -$5.22
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?